心脏神经调节用于心室节律失常:当前状态和未来的前景. 一个全面的审查
Pierre Groussin1, Donovan Decaudin1, Melvyn Dezecot1
1Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.
Trends in cardiovascular medicine
|May 14, 2025
概括
神经调节可以在其他疗法失败时为电风暴提供先进的治疗. 本综述探讨了针对自主神经系统的现有和正在发展的技术,用于耐火性心室节律失常.
科学领域:
- 电子生理学 电子生理学
- 自主神经系统研究 自主神经系统研究
- 心脏病学 心脏病学
背景情况:
- 电风暴的特点是耐火性心室节律失常,这给临床带来了重大挑战.
- 传统的治疗方法,如抗不律性药物和导管切除,往往是不够的.
- 神经调节已经成为一种关键的治疗策略,随着理解自主神经系统的进步而发展.
研究的目的:
- 审查当前用于管理电风暴的神经调节技术.
- 突出神经调节从动物研究到临床应用的演变.
- 讨论神经调节治疗耐火性心室节律失常的新兴途径.
主要方法:
- 对电风暴神经调节的现有文献的审查.
- 在心脏病学中分析自主神经系统调制的历史发展.
- 探索动物模型和人类研究对交感调制的探索.
主要成果:
- 神经调节技术已经多样化,为耐火性心律失常患者提供各种替代方案.
- 交感调制最初在动物模型中探索,在2000年代获得了临床势头,并在2010年代扩大.
- 目前正在研究神经调节的有希望的未来发展,主要是在临床前的环境中.
结论:
- 神经调节是管理电风暴的重要和不断发展的方法.
- 对自主神经系统的理解对于开发这些疗法至关重要.
- 持续的研究,特别是动物模型,对于推进神经调节策略至关重要.
相关概念视频
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753


